Schaeffers Investment Research
•Business
Business & Economics
Biotech Stock for Options Bears to Target Right Now
Summary
Nutrition label
75% Informative
Crispr Therapeutics Inc's June rally appears to be coming to an end.
The shares are looking to snap a seven-day win streak, down 0.6% at $ 42.69 at last glance.
After hitting its highest level since March , the stock is now flashing a historically bearish signal on the charts.
VR Score
74
Informative language
73
Neutral language
40
Article tone
formal
Language
English
Language complexity
31
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
1
Source diversity
1
Affiliate links
no affiliate links